FDA product code DLR: Hemagglutination Inhibition, Morphine

DLR is the FDA product code for hemagglutination inhibition, morphine. It is a Class II device, regulated under 21 CFR 862.3640 and reviewed by the Clinical Toxicology panel. FDA has cleared 2 510(k) submissions under DLR, from 2 different applicants. The average 510(k) review took 48 days (median 48).

Classification

FieldValue
Device nameHemagglutination Inhibition, Morphine
Device classClass II
Regulation21 CFR 862.3640
Review panelTX — Clinical Toxicology
Medical specialtyClinical Toxicology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every DLR clearance

Top DLR applicants

ApplicantClearancesLatest
Technam, Inc.11979-10-17
J.T. Baker Chemical Co.11976-07-20

Most recent DLR clearances

510(k)ApplicantDeviceDecision dateReview days
K791551Technam, Inc.HI-M-TEST MORPHINE1979-10-1764
K760074J.T. Baker Chemical Co.KIT, MORPHINE (TOXI-PAK IMMUNO HI)1976-07-2032

Recalls for DLR devices

openFDA lists no recalls for product code DLR.

Frequently asked questions

What is FDA product code DLR?

DLR is the FDA product code for hemagglutination inhibition, morphine. It is a Class II device, regulated under 21 CFR 862.3640 and reviewed by the Clinical Toxicology panel.

What device class is DLR?

Class II, regulation 21 CFR 862.3640. Typical premarket route: 510(k).

How long does a 510(k) take for product code DLR?

Across 2 cleared submissions the average was 48 days from receipt to decision (median 48).

Which companies have the most DLR clearances?

Technam, Inc. (1); J.T. Baker Chemical Co. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Toxicology product codes · FDA product code lookup · 510(k) database search · 510(k) review times